Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPHK2 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
RPL18 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
DBP - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
FAM83E - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
CA11 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
SPACA4 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
SEC1P - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
NTN5 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
SULT2B1 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
FUT2 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
LMTK3 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
CYTH2 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on